Literature DB >> 32606401

Temprian Therapeutics: developing a gene-based treatment for vitiligo.

Charles Schmidt.   

Abstract

Keywords:  Biotechnology; Drug discovery; Stem cells; Therapeutics

Year:  2020        PMID: 32606401     DOI: 10.1038/d41586-020-01808-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  HSP70iQ435A-Encoding DNA Repigments Vitiligo Lesions in Sinclair Swine.

Authors:  Steven W Henning; Manuel F Fernandez; James P Mahon; Richard Duff; Farshid Azarafrooz; José A Guevara-Patiño; Alfred W Rademaker; Andrew L Salzman; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2018-07-19       Impact factor: 8.551

2.  Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

Authors:  Jeffrey A Mosenson; Andrew Zloza; John D Nieland; Elizabeth Garrett-Mayer; Jonathan M Eby; Erica J Huelsmann; Previn Kumar; Cecele J Denman; Andrew T Lacek; Frederick J Kohlhapp; Ahmad Alamiri; Tasha Hughes; Steven D Bines; Howard L Kaufman; Andreas Overbeck; Shikhar Mehrotra; Claudia Hernandez; Michael I Nishimura; Jose A Guevara-Patino; I Caroline Le Poole
Journal:  Sci Transl Med       Date:  2013-02-27       Impact factor: 17.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.